CART19

CD19-directed chimeric antigen receptor T cells · Children's Hospital of Philadelphia

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CART19, covering 2017-02-28 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus [Phase 1, Phase 2]